Navigation Links
Bipolar Risk Gene Identified

Bipolar disorder is otherwise called as maniac-depressive illness. The disease incidence is about one in fifty. But the sad state is that one in six people who suffer from the disorder are likely to commit suicide.//

Hence extensive research was done on this disease to identify the gene and also develop various treatment modalities. Dr. Ian Blair conducted a study which revealed the bipolar risk gene.

The research was collaborative effort from both the Garvan Institute of Medical Research and University of New South Wales. This research would help many patients suffering from this disorder as it shows that certain people who have this gene are at a higher risk of developing Bipolar disorder.

Dr. Ian Blair published his work in the journal molecular psychiatry. They studied a wide rage of people including unrelated patients, and therapeutic drug mouse models and a large number of samples.

At the end they found that the gene responsible to increase the risk of this disorder to be the FAT gene. It codes for proteins which connect the brain cells.

But the exact mechanism of how the gene (FAT) increases the risk of developing bipolar disorder is still a mystery which has to be unraveled by conducting further research.

The treatment of this disorder is usually lithium. Lithium is apparently the first mood-stabilizing agent approved by the U.S. Food and Drug Administration (FDA).

But the mode of action of lithium is not yet understood in detail. Lithium also has few disadvantages like weight gain, kidney problems, tremor etc.

Dr Blair’s reports that lithium alters the FAT gene and its expression along with the other FAT proteins associated in increasing the risk of bipolar disorder.

In conclusion the scientist tells that further research is necessary to identify the mode of action of the FAT gene and develop new medicines that have no side-effects as lithium.


'"/>




Related medicine news :

1. Psychosocial Disability Varies In Accordance With Bipolar Symptom Changes
2. Seroquel to Treat Depression In Case Of Bipolar Disorder
3. Researchers Identify Gene Connected To Bipolar Disorder
4. Mood Stabilizing drugs for Bipolar disorder
5. Bipolar Disorder Not Being Accurately Diagnosed By Doctors In UK
6. Promising Care Model For Bipolar Disorder
7. Research on Bipolar Disorder Launched
8. Is Extreme Irritability - a Childhood Bipolar Disorder?
9. Antidepressant Medication Has No Effect on Bipolar Patients
10. Intensive Psychotherapy Effective in Treating Bipolar Disorder
11. Lithium Increases Gray Matter in Bipolar Brains
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home of ... manage stress and anxiety. , “Buzzies change the way we interact with stress ... Buzzies. , Since its launch date in December 2016, The TouchPoint Solution has sold ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... management and workflow solutions, today named The Resource Group as their 2016 Microsoft ... and partner conference in Newport Beach, CA. The award recognizes The Resource ...
(Date:3/23/2017)... ... 23, 2017 , ... According to the National Sleep Foundation , poor ... the only cause of the sunken-eye look, which can include dark circles or bags ... poor health are likely due to genetics, dehydration, allergies, and losing fat beneath the ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... FACIS Monthly Monitoring Healthcare products at competitive pricing. Verisys through ... sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are delighted to ...
(Date:3/23/2017)... ... March 23, 2017 , ... On 2 March ... the US Special Operations Command’s Patriot Award. The award was presented by the ... Force Dagger Foundation for its significant and enduring support to the command. ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017   Icertis , the leading ... the cloud, today announced an upgrade to the ... to improve clinical trials contract management. Built on ... the solution speeds up clinical trial contracting while ... (CRO). "The pharmaceutical industry is ...
(Date:3/23/2017)... 23, 2017  Interpace Diagnostics Group, Inc. (NASDAQ: ... integrated commercial company that provides clinically useful molecular ... it has entered into agreements to successfully restructure ... ("RedPath") and concurrently terminate its royalty and milestone ... debt to RedPath amounting to $9.34 million is ...
(Date:3/23/2017)... 2017  Additive Orthopaedics, LLC., an early stage ... kicked off a multi-centered clinical study to measure ... According to Brian McLaughlin , ... structures have already shown tremendous post-operative success and ... wedges from which we have seen evidence of ...
Breaking Medicine Technology: